Biomarkers of World Trade Center Particulate Matter Exposure: Physiology of distal airway and blood biomarkers that predict FEV1 decline
Supporting Files
-
6 2015
-
File Language:
English
Details
-
Alternative Title:Semin Respir Crit Care Med
-
Personal Author:
-
Description:Biomarkers can be important predictors of disease severity and progression. The intense exposure to particulates and other toxins from the destruction of the World Trade Center (WTC) overwhelmed the lung's normal protective barriers. The Fire Department of New York (FDNY) cohort not only had baseline pre-exposure lung function measures but also had serum samples banked soon after their WTC exposure. This well-phenotyped group of highly exposed first responders is an ideal cohort for biomarker discovery and eventual validation. Disease progression was heterogeneous in this group in that some individuals subsequently developed abnormal lung function while others recovered. Airflow obstruction predominated in WTC-exposed patients who were symptomatic. Multiple independent disease pathways may cause this abnormal FEV1 after irritant exposure. WTC exposure activates one or more of these pathways causing abnormal FEV1 in an individual. Our hypothesis was that serum biomarkers expressed within 6 months after WTC exposure reflect active disease pathways and predict subsequent development or protection from abnormal FEV1 below the lower limit of normal known as WTC-Lung Injury (WTC-LI). We utilized a nested case-cohort control design of previously healthy never smokers who sought subspecialty pulmonary evaluation to explore predictive biomarkers of WTC-LI. We have identified biomarkers of inflammation, metabolic derangement, protease/antiprotease balance, and vascular injury expressed in serum within 6 months of WTC exposure that were predictive of their FEV1 up to 7 years after their WTC exposure. Predicting future risk of airway injury after particulate exposures can focus monitoring and early treatment on a subset of patients in greatest need of these services.
-
Subjects:
-
Source:Semin Respir Crit Care Med. 36(3):323-333
-
Pubmed ID:26024341
-
Pubmed Central ID:PMC4755483
-
Document Type:
-
Funding:UL1 TR001445/TR/NCATS NIH HHSUnited States/ ; U10 OH008243/OH/NIOSH CDC HHSUnited States/ ; U10 OH008242/OH/NIOSH CDC HHSUnited States/ ; R01HL057879/HL/NHLBI NIH HHSUnited States/ ; UL1 RR029893/RR/NCRR NIH HHSUnited States/ ; K23HL084191/HL/NHLBI NIH HHSUnited States/ ; U10-OH008242/OH/NIOSH CDC HHSUnited States/ ; K24 AI080298/AI/NIAID NIH HHSUnited States/ ; UL1TR000038/TR/NCATS NIH HHSUnited States/ ; K24A1080298/PHS HHSUnited States/ ; UL1RR029893/RR/NCRR NIH HHSUnited States/ ; U10-OH008243/OH/NIOSH CDC HHSUnited States/ ; K23 HL084191/HL/NHLBI NIH HHSUnited States/ ; P30 CA013330/CA/NCI NIH HHSUnited States/ ; UL1 TR000038/TR/NCATS NIH HHSUnited States/ ; R01 HL057879/HL/NHLBI NIH HHSUnited States/ ; R01 HL119326/HL/NHLBI NIH HHSUnited States/
-
Volume:36
-
Issue:3
-
Collection(s):
-
Main Document Checksum:urn:sha256:ee732751cf68d24ca1b6bed7474aeb327ace383c55943e58b77013bad05bac9d
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access